Related Experiment Video
Updated: Jul 10, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Retinal haemodynamics in individuals with well-controlled type 1 diabetes
M Lorenzi1, G T Feke, E Cagliero
1Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, and Diabetes Center and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. mara.lorenzi@schepens.harvard.edu
Insights
Type 1 diabetes patients with good blood sugar control and no retinopathy show normal retinal blood flow. Subtle abnormalities may only appear under stress testing, not at rest.
Area of Science:
- Ophthalmology
- Diabetology
- Vascular Biology
Background:
- Retinal hemodynamic abnormalities may precede clinical diabetic retinopathy in type 1 diabetes.
- Good glycemic control, emphasized since the Diabetes Control and Complications Trial (DCCT), influences diabetic retinopathy progression.
- Investigating early diabetic microangiopathy markers is crucial for disease management.
Purpose of the Study:
- To assess if type 1 diabetes patients in the post-DCCT era with minimal retinopathy exhibit retinal hemodynamic abnormalities.
- To determine if current management practices mitigate early vascular changes in the retina.
- To evaluate retinal blood flow, speed, and arterial diameter in well-controlled type 1 diabetes.
Main Methods:
- Laser Doppler flowmetry used to measure retinal hemodynamics.
- Study included 33 type 1 diabetic individuals (no/minimal retinopathy) and 31 controls.
- Participants excluded vasoactive medications; blood glucose maintained between 3.8-11.1 mmol/l.
Main Results:
- Type 1 diabetes group had good glycemic control (HbA1c 7.5+/-1.2%).
- No significant differences in retinal blood speed, arterial diameter, or blood flow were observed between diabetic and control groups.
- This suggests stable retinal circulation in well-controlled, early-stage type 1 diabetes.
Conclusions:
- Type 1 diabetes patients with minimal retinopathy and good glycemic control do not display resting retinal hemodynamic abnormalities.
- Early microvascular changes in the retina may not be detectable at steady state in this cohort.
- Further studies involving vascular stress tests may be needed to reveal subtle retinal abnormalities.
Aims/Hypothesis:
Abnormalities in retinal haemodynamics have been reported in patients with type 1 diabetes in advance of clinical retinopathy. These abnormalities could therefore be useful as early markers or surrogate endpoints for studying the microangiopathy. Since the DCCT, the increased focus on good glycaemic control is changing the natural history of diabetic retinopathy. Based on this, the aim of this study was to investigate whether patients with type 1 diabetes treated entirely or mostly in the post-DCCT era and tested in the absence of confounding factors show retinal haemodynamic abnormalities.
Methods:
We measured retinal haemodynamics by laser Doppler flowmetry in 33 type 1 diabetic individuals with no or minimal retinopathy (age 30+/-7 years, duration of diabetes 8.8+/-4.6 years, 9% showing microaneurysms), and 31 age- and sex-matched non-diabetic controls. The study participants were not taking vasoactive medications, and blood glucose at the time of haemodynamic measurements was required to be between 3.8 and 11.1 mmol/l.
Results:
HbA1c was 7.5+/-1.2% and blood glucose 7.7+/-2.8 mmol/l in these type 1 diabetic individuals, indicating relatively good glycaemic control. Retinal blood speed, arterial diameter and blood flow were not different between the diabetic individuals and the matched controls.
Conclusions/Interpretation:
Type 1 diabetic patients with no or minimal retinopathy who maintain relatively good glycaemic control do not show abnormalities of the retinal circulation at steady state, even after several years of diabetes. In such patients it may be necessary to test the vascular response to challenges to uncover any subtle abnormalities of the retinal vessels.
Related Concept Videos
Diabetic Retinopathy
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations

